Global Pharmaceuticals & Biotech Breakout Stocks

Forte Biosciences

Market Cap: US$1.3b

Operates as a clinical-stage biopharmaceutical company in the United States.

Anhui Wanbang Pharmaceutical TechnologyLtd

Market Cap: CN¥5.7b

Anhui Wanbang Pharmaceutical Technology Co.,Ltd.

GlaxoSmithKlineE

Market Cap: ج.م11.9b

Engages in production of pharmaceutical chemicals.

Pyxis Oncology

Market Cap: US$165.4m

A clinical stage company, engages in the development of therapeutics to treat solid tumors.

Entera Bio

Market Cap: US$101.0m

A clinical stage company, engages in the development of oral peptides and protein replacement therapies in Israel and internationally.

Cell Source

Market Cap: US$44.2m

A biotechnology company, engages in developing cell therapy treatments based on the management of immune tolerance.

EOM Pharmaceuticals Holdings

Market Cap: US$26.4m

A clinical-stage biotechnology company, focuses on the development of drugs to transform therapeutic paradigms and enhance quality of life in patients suffering from debilitating and deadly diseases in the United States.

Intravenous Infusions

Market Cap: GH₵181.1m

A pharmaceutical company, engages in the manufacturing and marketing of intravenous infusions and small volume injectables for therapeutic purposes in Ghana and the West African sub-region.

Green Zebras Spolka Akcyjna

Market Cap: zł18.4m

Produces and sells herbal extracts focusing on Polish herbs and adaptogenic plants, mushrooms, fruits, and spices in Poland.

Panacea Life Sciences Holdings

Market Cap: US$4.5m

Operates as a holding company, researchers, develops, manufactures, produces, and distributes cannabinoids, mushrooms, kratom, and other natural, plant-based ingredients and products for humans and animals.

Vaccinex

Market Cap: US$3.2m

A clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat cancer, neurodegenerative diseases, and autoimmune disorders.

International Stem Cell

Market Cap: US$2.5m

A clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally.

Innovation Pharmaceuticals

Market Cap: US$1.4m

A clinical stage biopharmaceutical company, develops small molecule therapies to treat inflammatory diseases, cancer, dermatology, and anti- infective.

PAO Group

Market Cap: US$382.0k

Focuses on alternative patient care treatments.

Myrexis

Market Cap: US$241.4k

Focuses on identifying, evaluating, and making financial investments in life sciences assets.

Cannonau

Market Cap: US$72.5k

Engages in the provision of cannabidiol based products.

Statera Biopharma

Market Cap: US$7.3k

Statera BioPharma, Inc., a clinical-stage biopharmaceutical company, develops novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses, and cancers based on a proprietary platform designed to rebalance the body’s immune system and restore homeostasis.

eFFECTOR Therapeutics

Market Cap: US$3.8k

A biopharmaceutical company, engages in the development of selective translation regulator inhibitors for the treatment of cancer.

ObsEva

Market Cap: US$117.0

A biopharmaceutical company, focuses on the development of novel therapies to improve women’s reproductive health.